Longitudinal Change in Trabecular Bone Score during and after Treatment of Osteoporosis in Postmenopausal Korean Women

키워드

참고문헌 (33)

1. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy, "Osteoporosis prevention, diagnosis, and therapy", JAMA, 285, pp.785~795 (2001)
2. van der Meulen MC, "Understanding bone strength: size isn't everything", Bone, 29, pp.101~104 (2001)
3. Johnell O, "Predictive value of BMD for hip and other fractures", J Bone Miner Res, 20, pp.1185~1194 (2005)
4. Cummings SR, "Clinical use of bone densitometry: scientific review", JAMA, 288, pp.1889~1897 (2002)
5. Miller PD, "Prediction of fracture risk in postmenopausal white women with peripheral bone densitometry: evidence from the National Osteoporosis Risk Assessment", J Bone Miner Res, 17, pp.2222~2230 (2002)
6. Pasco JA, "The population burden of fractures originates in women with osteopenia, not osteoporosis", Osteoporos Int, 17, pp.1404~1409 (2006)
7. WHO Study Group, "Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group", World Health Organ Tech Rep Ser, 843, pp.1~129 (1994)
8. Chen P, "Change in lumbar spine BMD and vertebral fracture risk reduction in teriparatide-treated postmenopausal women with osteoporosis", J Bone Miner Res, 21, pp.1785~1790 (2006)
9. Sarkar S, "Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy", J Bone Miner Res, 17, pp.1~10 (2002)
10. Seeman E, "Bone quality-the material and structural basis of bone strength and fragility", N Engl J Med, 354, pp.2250~2261 (2006)
11. Silva BC, "Trabecular bone score: a noninvasive analytical method based upon the DXA image", J Bone Miner Res, 29, pp.518~530 (2014)
12. Hans D, "Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: the Manitoba study", J Bone Miner Res, 26, pp.2762~2769 (2011)
13. Briot K, "Added value of trabecular bone score to bone mineral density for prediction of osteoporotic fractures in postmenopausal women: the OPUS study", Bone, 57, pp.232~236 (2013)
14. Krueger D, "Spine trabecular bone score subsequent to bone mineral density improves fracture discrimination in women", J Clin Densitom, 17, pp.60~65 (2014)
15. Krieg MA, "Effects of anti-resorptive agents on trabecular bone score (TBS) in older women", Osteoporos Int, 24, pp.1073~1078 (2013)
16. Dufresne TE, "Risedronate preserves bone architecture in early postmenopausal women in 1 year as measured by three-dimensional microcomputed tomography", Calcif Tissue Int, 73, pp.423~432 (2003)
17. Popp AW, "Effects of zoledronate versus placebo on spine bone mineral density and microarchitecture assessed by the trabecular bone score in postmenopausal women with osteoporosis: a three-year study", J Bone Miner Res, 28, pp.449~454 (2013)
18. Senn C, "Comparative effects of teriparatide and ibandronate on spine bone mineral density (BMD) and microarchitecture (TBS) in postmenopausal women with osteoporosis: a 2-year open-label study", Osteoporos Int, 25, pp.1945~1951 (2014)
19. "Osteoporosis fact sheet 2014" (2014)[URL]
20. Eastell R, "Bisphosphonates for postmenopausal osteoporosis", Bone, 49, pp.82~88 (2011)
21. Russell RG, "Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy", Osteoporos Int, 19, pp.733~759 (2008)
22. Eastell R, "Effect of stopping risedronate after long-term treatment on bone turnover", J Clin Endocrinol Metab, 96, pp.3367~3373 (2011)
23. Gedmintas L, "Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: a systematic review and meta-analysis", J Bone Miner Res, 28, pp.1729~1737 (2013)
24. Imai K, "Assessment of vertebral fracture risk and therapeutic effects of alendronate in postmenopausal women using a quantitative computed tomography-based nonlinear finite element method", Osteoporos Int, 20, pp.801~810 (2009)
25. Burghardt AJ, "A longitudinal HR-pQCT study of alendronate treatment in postmenopausal women with low bone density: Relations among density, cortical and trabecular microarchitecture, biomechanics, and bone turnover", J Bone Miner Res, 25, pp.2558~2571 (2010)
26. Winzenrieth R, "Three-dimensional (3D) microarchitecture correlations with 2D projection image gray-level variations assessed by trabecular bone score using high-resolution computed tomographic acquisitions: effects of resolution and noise", J Clin Densitom, 16, pp.287~296 (2013)
27. Di Gregorio S, "Comparison between different bone treatments on areal bone mineral density (aBMD) and bone microarchitectural texture as assessed by the trabecular bone score (TBS)", Bone, 75, pp.138~143 (2015)
28. Rizzoli R, "Effects of strontium ranelate and alendronate on bone microstructure in women with osteoporosis. Results of a 2-year study", Osteoporos Int, 23, pp.305~315 (2012)
29. Black DM, "Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial", JAMA, 296, pp.2927~2938 (2006)
30. Black DM, "The effect of 6 versus 9 years of zoledronic acid treatment in osteoporosis: a randomized second extension to the HORIZON-Pivotal Fracture Trial (PFT)", J Bone Miner Res, 30, pp.934~944 (2015)
31. Neele SJ, "Effect of 1 year of discontinuation of raloxifene or estrogen therapy on bone mineral density after 5 years of treatment in healthy postmenopausal women", Bone, 30, pp.599~603 (2002)
32. Bone HG, "Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass", J Clin Endocrinol Metab, 96, pp.972~980 (2011)
33. Kalder M, "Effects of exemestane and tamoxifen treatment on bone texture analysis assessed by TBS in comparison with bone mineral density assessed by DXA in women with breast cancer", J Clin Densitom, 17, pp.66~71 (2014)

관련 논문AI추천